Ingevity (NGVT) Common Equity (2016 - 2025)
Ingevity (NGVT) has disclosed Common Equity for 11 consecutive years, with $29.7 million as the latest value for Q4 2025.
- On a quarterly basis, Common Equity fell 84.78% to $29.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.7 million, a 84.78% decrease, with the full-year FY2025 number at $29.7 million, down 84.78% from a year prior.
- Common Equity was $29.7 million for Q4 2025 at Ingevity, down from $138.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $725.7 million in Q1 2023 to a low of $29.7 million in Q4 2025.
- A 5-year average of $495.8 million and a median of $639.2 million in 2021 define the central range for Common Equity.
- Peak YoY movement for Common Equity: soared 2617.58% in 2021, then tumbled 84.78% in 2025.
- Ingevity's Common Equity stood at $673.8 million in 2021, then rose by 3.64% to $698.3 million in 2022, then decreased by 9.58% to $631.4 million in 2023, then tumbled by 69.08% to $195.2 million in 2024, then crashed by 84.78% to $29.7 million in 2025.
- Per Business Quant, the three most recent readings for NGVT's Common Equity are $29.7 million (Q4 2025), $138.1 million (Q3 2025), and $120.7 million (Q2 2025).